STAMFORD, Conn.--(BUSINESS WIRE)--(Booth #301) – FUJIFILM Medical Systems U.S.A., Inc. will demonstrate the next generation of Synapse Cardiovascular, that will allow cardiologists and clinical professionals to enhance patient care through advanced reporting applications at the 25th Annual Scientific Session of the American Society of Echocardiography in Portland, Oregon.
“With Synapse, our users are able to perform their job more efficiently and ultimately allow them to concentrate more on the patient and improve patient outcomes,” said Jim Morgan, vice president of Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. “At ASE, we will demonstrate an upcoming clinical reporting platform that will feature a new user interface and layout options that has the potential to benefit your entire practice.”
Following is a summary of offerings:
Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret images and compose structured reports with a streamlined workflow. The system has powerful capabilities designed specifically for, echocardiography, cardiac catheterization and invasive peripheral vascular, nuclear cardiology, vascular ultrasound, ECG management, CT, and Cardiac MRI workflows. Fujifilm's Synapse Cardiovascular is an essential addition to any clinical workplace. At the show, attendees will also be able to see a works-in-progress demonstration of Synapse Cardiovascular 6.0*, which will showcase intended future functionality for echocardiography.
Fujifilm will also share the benefits of its zero footprint mobile application, Synapse Mobility. The application enables access to Fujifilm’s suite of Synapse products from hand-held devices, in addition to browser independence. Access to non-DICOM information from the Synapse VNA has been added to complete the universal viewing capability from EMRs such as Epic Hyperspace. Synapse Mobility continues to demonstrate its diagnostic capability for both browser and mobile versions.
To register for a demonstration at ASE 2014, please visit: http://www.fujimed.com/gateway/ase/2014/registration.html.
*Synapse Cardiovascular 6.0 will be made commercially available in the U.S. upon receipt of FDA clearance
For more information about Synapse, please visit: http://cardiovascular.fujimed.com/
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2014, the company had global revenues of $23.7 billion, at an exchange rate of 103 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.